 Hari Eswaran
Concepts (222)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetoencephalography | 30 | 2024 | 118 | 9.010 |
Why?
| | Magnetocardiography | 12 | 2024 | 56 | 5.790 |
Why?
| | Fetus | 24 | 2024 | 217 | 5.650 |
Why?
| | Heart Rate, Fetal | 11 | 2024 | 75 | 3.750 |
Why?
| | Pregnancy | 51 | 2024 | 2607 | 3.640 |
Why?
| | Telemedicine | 13 | 2024 | 448 | 3.400 |
Why?
| | Brain | 20 | 2020 | 1328 | 3.320 |
Why?
| | Fetal Development | 9 | 2023 | 60 | 2.200 |
Why?
| | Uterine Contraction | 6 | 2016 | 37 | 2.150 |
Why?
| | Fetal Heart | 5 | 2023 | 32 | 2.130 |
Why?
| | Pelvic Floor | 3 | 2024 | 51 | 2.070 |
Why?
| | Female | 67 | 2024 | 26472 | 1.790 |
Why?
| | Prenatal Diagnosis | 6 | 2021 | 107 | 1.780 |
Why?
| | Electromyography | 4 | 2018 | 131 | 1.760 |
Why?
| | Pregnant Women | 3 | 2023 | 77 | 1.700 |
Why?
| | Fetal Monitoring | 5 | 2018 | 40 | 1.660 |
Why?
| | Gestational Age | 21 | 2023 | 421 | 1.620 |
Why?
| | Evoked Potentials, Auditory | 12 | 2020 | 101 | 1.590 |
Why?
| | Electroencephalography | 6 | 2020 | 306 | 1.580 |
Why?
| | Humans | 76 | 2024 | 49974 | 1.390 |
Why?
| | Pregnancy Complications | 3 | 2023 | 382 | 1.240 |
Why?
| | Myography | 4 | 2024 | 15 | 1.240 |
Why?
| | Feasibility Studies | 4 | 2024 | 375 | 1.210 |
Why?
| | Evoked Potentials, Visual | 8 | 2020 | 37 | 1.170 |
Why?
| | Infant, Newborn | 19 | 2023 | 2772 | 1.160 |
Why?
| | Buprenorphine | 2 | 2019 | 140 | 1.130 |
Why?
| | Algorithms | 6 | 2020 | 615 | 1.100 |
Why?
| | Adult | 25 | 2024 | 13236 | 1.040 |
Why?
| | Brain Mapping | 6 | 2013 | 235 | 1.030 |
Why?
| | Aftercare | 2 | 2022 | 75 | 1.010 |
Why?
| | Obstetric Labor, Premature | 4 | 2016 | 38 | 1.000 |
Why?
| | Signal Processing, Computer-Assisted | 4 | 2018 | 70 | 1.000 |
Why?
| | Pregnancy Trimester, Third | 6 | 2023 | 65 | 1.000 |
Why?
| | Premature Birth | 3 | 2021 | 147 | 0.940 |
Why?
| | Brain Waves | 2 | 2016 | 18 | 0.930 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2024 | 33 | 0.910 |
Why?
| | Fetal Blood | 1 | 2024 | 68 | 0.910 |
Why?
| | Muscle Strength | 1 | 2024 | 124 | 0.900 |
Why?
| | Interleukin-6 | 1 | 2024 | 264 | 0.840 |
Why?
| | Diabetes, Gestational | 1 | 2023 | 53 | 0.840 |
Why?
| | Evoked Potentials | 2 | 2021 | 72 | 0.830 |
Why?
| | Prenatal Care | 1 | 2023 | 108 | 0.800 |
Why?
| | Auditory Cortex | 2 | 2020 | 22 | 0.800 |
Why?
| | Hydroxyprogesterones | 1 | 2021 | 8 | 0.770 |
Why?
| | Delivery of Health Care | 3 | 2024 | 309 | 0.770 |
Why?
| | Hypertension | 2 | 2023 | 533 | 0.760 |
Why?
| | Opioid-Related Disorders | 3 | 2024 | 381 | 0.750 |
Why?
| | Heart Rate | 3 | 2023 | 293 | 0.740 |
Why?
| | Pre-Eclampsia | 2 | 2020 | 55 | 0.730 |
Why?
| | Breast Feeding | 1 | 2022 | 187 | 0.720 |
Why?
| | Pregnancy in Diabetics | 1 | 2020 | 31 | 0.700 |
Why?
| | Diabetes Mellitus | 2 | 2021 | 285 | 0.690 |
Why?
| | Pregnancy Outcome | 4 | 2023 | 237 | 0.680 |
Why?
| | Obstetrics | 2 | 2020 | 88 | 0.630 |
Why?
| | Narcotic Antagonists | 1 | 2019 | 135 | 0.630 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 89 | 0.620 |
Why?
| | Pilot Projects | 4 | 2023 | 699 | 0.610 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 595 | 0.610 |
Why?
| | Cardiotocography | 2 | 2011 | 8 | 0.610 |
Why?
| | Labor Onset | 2 | 2010 | 4 | 0.600 |
Why?
| | Magnetics | 4 | 2009 | 39 | 0.590 |
Why?
| | Monitoring, Ambulatory | 1 | 2017 | 8 | 0.590 |
Why?
| | Postpartum Period | 2 | 2020 | 113 | 0.580 |
Why?
| | Action Potentials | 3 | 2018 | 132 | 0.570 |
Why?
| | Young Adult | 8 | 2024 | 3958 | 0.570 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 43 | 0.570 |
Why?
| | Sleep | 3 | 2013 | 184 | 0.560 |
Why?
| | United States | 10 | 2024 | 4860 | 0.560 |
Why?
| | Magnesium Sulfate | 1 | 2016 | 13 | 0.560 |
Why?
| | Health Services Accessibility | 3 | 2022 | 398 | 0.550 |
Why?
| | Quality of Life | 1 | 2022 | 836 | 0.540 |
Why?
| | Colposcopy | 1 | 2016 | 18 | 0.540 |
Why?
| | Pregnancy, High-Risk | 5 | 2017 | 60 | 0.540 |
Why?
| | Disposable Equipment | 1 | 2016 | 5 | 0.540 |
Why?
| | Uterine Monitoring | 1 | 2016 | 6 | 0.540 |
Why?
| | Appointments and Schedules | 1 | 2015 | 23 | 0.520 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 105 | 0.520 |
Why?
| | Anticonvulsants | 1 | 2016 | 121 | 0.510 |
Why?
| | Abdomen | 1 | 2015 | 76 | 0.510 |
Why?
| | Gynecology | 1 | 2015 | 49 | 0.500 |
Why?
| | Ambulatory Care Facilities | 1 | 2015 | 125 | 0.490 |
Why?
| | Muscle, Skeletal | 2 | 2018 | 750 | 0.480 |
Why?
| | Rural Health Services | 1 | 2016 | 166 | 0.460 |
Why?
| | Monitoring, Physiologic | 3 | 2023 | 120 | 0.460 |
Why?
| | Diagnosis, Computer-Assisted | 2 | 2011 | 48 | 0.460 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2016 | 277 | 0.440 |
Why?
| | Analgesics, Opioid | 1 | 2018 | 552 | 0.430 |
Why?
| | Medicaid | 4 | 2023 | 257 | 0.420 |
Why?
| | Prospective Studies | 5 | 2022 | 2364 | 0.420 |
Why?
| | Uterus | 3 | 2015 | 94 | 0.400 |
Why?
| | Medicare | 2 | 2023 | 246 | 0.390 |
Why?
| | Arkansas | 7 | 2024 | 1977 | 0.390 |
Why?
| | Muscle Contraction | 2 | 2024 | 105 | 0.390 |
Why?
| | Fetal Organ Maturity | 1 | 2011 | 9 | 0.380 |
Why?
| | Acoustic Stimulation | 6 | 2021 | 97 | 0.380 |
Why?
| | Photic Stimulation | 4 | 2021 | 60 | 0.370 |
Why?
| | Patient Discharge | 2 | 2022 | 320 | 0.350 |
Why?
| | Myometrium | 1 | 2010 | 14 | 0.350 |
Why?
| | Male | 16 | 2024 | 25241 | 0.350 |
Why?
| | Reproducibility of Results | 6 | 2019 | 1193 | 0.350 |
Why?
| | Cost-Benefit Analysis | 2 | 2023 | 274 | 0.330 |
Why?
| | Labor, Obstetric | 1 | 2009 | 45 | 0.320 |
Why?
| | Cohort Studies | 4 | 2020 | 1422 | 0.320 |
Why?
| | Pandemics | 5 | 2024 | 559 | 0.310 |
Why?
| | Habituation, Psychophysiologic | 1 | 2008 | 33 | 0.310 |
Why?
| | Time Factors | 4 | 2018 | 2903 | 0.280 |
Why?
| | Adolescent | 5 | 2022 | 6356 | 0.260 |
Why?
| | Patient Acceptance of Health Care | 3 | 2023 | 329 | 0.260 |
Why?
| | Retrospective Studies | 6 | 2024 | 6108 | 0.260 |
Why?
| | Cesarean Section | 2 | 2024 | 187 | 0.250 |
Why?
| | Visual Pathways | 1 | 2004 | 12 | 0.250 |
Why?
| | Optical Devices | 1 | 2024 | 4 | 0.240 |
Why?
| | Optical Phenomena | 1 | 2024 | 11 | 0.240 |
Why?
| | Infant | 3 | 2023 | 3567 | 0.240 |
Why?
| | Pressure | 1 | 2024 | 105 | 0.240 |
Why?
| | Cyanosis | 1 | 2024 | 18 | 0.240 |
Why?
| | Rest | 1 | 2024 | 63 | 0.240 |
Why?
| | Heart Conduction System | 1 | 2003 | 24 | 0.220 |
Why?
| | Morbidity | 1 | 2023 | 133 | 0.220 |
Why?
| | Case-Control Studies | 3 | 2020 | 1131 | 0.220 |
Why?
| | Embryonic and Fetal Development | 1 | 2002 | 20 | 0.210 |
Why?
| | Autonomic Nervous System | 1 | 2023 | 57 | 0.210 |
Why?
| | Cooperative Behavior | 2 | 2014 | 228 | 0.210 |
Why?
| | Lactation | 1 | 2022 | 62 | 0.210 |
Why?
| | Socioeconomic Factors | 3 | 2023 | 581 | 0.200 |
Why?
| | Health Care Costs | 1 | 2023 | 170 | 0.200 |
Why?
| | Sensitivity and Specificity | 3 | 2011 | 861 | 0.200 |
Why?
| | Comorbidity | 1 | 2023 | 615 | 0.200 |
Why?
| | Biomedical Research | 2 | 2014 | 237 | 0.190 |
Why?
| | Signal-To-Noise Ratio | 1 | 2021 | 19 | 0.190 |
Why?
| | Fetal Movement | 2 | 2018 | 20 | 0.190 |
Why?
| | Prevalence | 1 | 2023 | 944 | 0.180 |
Why?
| | ROC Curve | 2 | 2018 | 232 | 0.180 |
Why?
| | Referral and Consultation | 1 | 2022 | 285 | 0.180 |
Why?
| | Auditory Perception | 1 | 2020 | 29 | 0.180 |
Why?
| | Subtraction Technique | 1 | 2020 | 14 | 0.180 |
Why?
| | Arrhythmias, Cardiac | 1 | 2021 | 95 | 0.180 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 903 | 0.180 |
Why?
| | Mothers | 1 | 2022 | 249 | 0.170 |
Why?
| | Hospitalization | 1 | 2023 | 652 | 0.170 |
Why?
| | Personal Satisfaction | 1 | 2019 | 75 | 0.170 |
Why?
| | Magnetic Fields | 1 | 2018 | 11 | 0.160 |
Why?
| | Manometry | 1 | 2018 | 22 | 0.160 |
Why?
| | Wakefulness | 2 | 2011 | 52 | 0.160 |
Why?
| | Vagina | 1 | 2018 | 45 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 549 | 0.160 |
Why?
| | Computer Simulation | 3 | 2015 | 280 | 0.150 |
Why?
| | Ultrasonography, Prenatal | 2 | 2013 | 188 | 0.150 |
Why?
| | Pulse | 1 | 2017 | 14 | 0.150 |
Why?
| | Attitude to Computers | 1 | 2017 | 18 | 0.150 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 35 | 0.150 |
Why?
| | Magnetometry | 1 | 2017 | 4 | 0.150 |
Why?
| | Optics and Photonics | 1 | 2017 | 12 | 0.140 |
Why?
| | Remote Consultation | 1 | 2017 | 29 | 0.140 |
Why?
| | Middle Aged | 5 | 2024 | 12069 | 0.140 |
Why?
| | Transportation | 1 | 2016 | 30 | 0.140 |
Why?
| | Cerebral Palsy | 1 | 2016 | 40 | 0.140 |
Why?
| | Radiography, Abdominal | 1 | 2015 | 27 | 0.130 |
Why?
| | Models, Organizational | 1 | 2015 | 59 | 0.130 |
Why?
| | Aged | 3 | 2023 | 9310 | 0.130 |
Why?
| | Sexual Behavior | 1 | 2016 | 117 | 0.130 |
Why?
| | Body Weight | 1 | 2017 | 513 | 0.120 |
Why?
| | Blood Pressure | 1 | 2017 | 512 | 0.120 |
Why?
| | Oxygen | 1 | 2017 | 326 | 0.120 |
Why?
| | Promethazine | 1 | 2014 | 12 | 0.120 |
Why?
| | Social Networking | 1 | 2014 | 15 | 0.120 |
Why?
| | Ondansetron | 1 | 2014 | 13 | 0.120 |
Why?
| | Reaction Time | 2 | 2005 | 216 | 0.120 |
Why?
| | Antiemetics | 1 | 2014 | 32 | 0.110 |
Why?
| | Child Development | 2 | 2014 | 190 | 0.110 |
Why?
| | Sleep Stages | 1 | 2013 | 45 | 0.110 |
Why?
| | Vomiting | 1 | 2014 | 75 | 0.110 |
Why?
| | Reference Values | 1 | 2013 | 310 | 0.110 |
Why?
| | Social Support | 1 | 2014 | 263 | 0.110 |
Why?
| | Software | 1 | 2014 | 273 | 0.100 |
Why?
| | Smoking | 1 | 2016 | 511 | 0.100 |
Why?
| | Child, Preschool | 1 | 2020 | 3871 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2014 | 186 | 0.100 |
Why?
| | Child | 1 | 2022 | 6847 | 0.090 |
Why?
| | Models, Neurological | 1 | 2010 | 58 | 0.090 |
Why?
| | Biological Clocks | 1 | 2009 | 19 | 0.090 |
Why?
| | Statistics as Topic | 1 | 2010 | 88 | 0.090 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 42 | 0.080 |
Why?
| | Electrophysiology | 1 | 2009 | 78 | 0.080 |
Why?
| | Patient Satisfaction | 2 | 2020 | 273 | 0.080 |
Why?
| | Delta Rhythm | 1 | 2007 | 7 | 0.080 |
Why?
| | Placental Insufficiency | 1 | 2007 | 4 | 0.070 |
Why?
| | Risk Factors | 1 | 2016 | 3613 | 0.070 |
Why?
| | Flecainide | 1 | 2006 | 5 | 0.070 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2006 | 79 | 0.070 |
Why?
| | Fetal Diseases | 1 | 2006 | 62 | 0.070 |
Why?
| | Tachycardia, Supraventricular | 1 | 2006 | 40 | 0.070 |
Why?
| | Pitch Perception | 1 | 2005 | 10 | 0.070 |
Why?
| | Spectrum Analysis | 1 | 2006 | 70 | 0.070 |
Why?
| | Labor Stage, First | 1 | 2004 | 9 | 0.060 |
Why?
| | Electrocardiography | 1 | 2006 | 257 | 0.060 |
Why?
| | Maternal Age | 1 | 2004 | 44 | 0.060 |
Why?
| | Insurance Coverage | 1 | 2024 | 103 | 0.060 |
Why?
| | Mortality | 1 | 2023 | 99 | 0.050 |
Why?
| | Hospitals, Private | 1 | 2022 | 3 | 0.050 |
Why?
| | Health Surveys | 1 | 2022 | 232 | 0.050 |
Why?
| | Triage | 1 | 2020 | 62 | 0.040 |
Why?
| | Emergency Service, Hospital | 1 | 2023 | 486 | 0.040 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 1557 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2014 | 688 | 0.040 |
Why?
| | Qualitative Research | 1 | 2020 | 329 | 0.040 |
Why?
| | Health Personnel | 1 | 2020 | 246 | 0.040 |
Why?
| | Telephone | 1 | 2017 | 70 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2023 | 3129 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 354 | 0.030 |
Why?
| | Schools, Medical | 1 | 2014 | 69 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 449 | 0.030 |
Why?
| | Rural Population | 1 | 2017 | 540 | 0.030 |
Why?
| | Diseases in Twins | 1 | 2006 | 15 | 0.020 |
Why?
| | Pregnancy, Multiple | 1 | 2006 | 23 | 0.020 |
Why?
| | Twins | 1 | 2006 | 33 | 0.020 |
Why?
| | Electromagnetic Fields | 1 | 2005 | 16 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2006 | 562 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2005 | 158 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2004 | 156 | 0.010 |
Why?
| | Age Factors | 1 | 2004 | 1087 | 0.010 |
Why?
| | Aging | 1 | 2005 | 687 | 0.010 |
Why?
|
|
Eswaran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|